Keystone Resort Floorplan
- Meeting Program
- Abstract Information
- Registration Information
- Scholarships / Awards
- My Account
NOTES:
This meeting will be conducted in English.
All programs are subject to change. Check this site for updates.
This meeting is part of the Global Health Series
Download Flyer
This meeting will be conducted in English.
All programs are subject to change. Check this site for updates.
This meeting is part of the Global Health Series
Download Flyer
No registration fees are used to fund entertainment or alcohol at this conference
The meeting will begin on Tuesday, June 6 with registration from 16:00 to 20:00 and a welcome mixer from 18:00 to 20:00. Conference events conclude on Saturday, June 10 with a closing plenary session from 17:00 to 19:00, followed by a social hour. We recommend return travel on Sunday, June 11 in order to fully experience the meeting.
TUESDAY, JUNE 6
WEDNESDAY, JUNE 7
THURSDAY, JUNE 8
FRIDAY, JUNE 9
SATURDAY, JUNE 10
SUNDAY, JUNE 11
Conference Program Print | View meeting in 12 hr (am/pm) time
The meeting will begin on Tuesday, June 6 with registration from 16:00 to 20:00 and a welcome mixer from 18:00 to 20:00. Conference events conclude on Saturday, June 10 with a closing plenary session from 17:00 to 19:00, followed by a social hour. We recommend return travel on Sunday, June 11 in order to fully experience the meeting.
TUESDAY, JUNE 6
08:00—09:30
Welcome and Keynote Session (Joint)
Anthony S. Fauci†,
, USA
Where Two Pandemics Meet: HIV and SARS-CoV-2
Where Two Pandemics Meet: HIV and SARS-CoV-2
Rafi Ahmed,
Emory University School of Medicine, USA
B Cell Biology in the Context of Infectious Diseases, Autoimmunity and B Cell Cancers
B Cell Biology in the Context of Infectious Diseases, Autoimmunity and B Cell Cancers
Coffee Break
09:50—11:30
How B Cells Function in Infectious Diseases (Joint)
Shane Crotty,
La Jolla Institute for Immunology, USA
Immune Memory to SARS-CoV-2 and COVID-19 Vaccines, and Lessons for HIV Vaccine Development
Immune Memory to SARS-CoV-2 and COVID-19 Vaccines, and Lessons for HIV Vaccine Development
Michel C. Nussenzweig,
HHMI/Rockefeller University, USA
Refining the B Cell Repertoire by Somatic Hypermutation and Class Switch Recombination
Refining the B Cell Repertoire by Somatic Hypermutation and Class Switch Recombination
Susan Moir,
NIAID, National Institutes of Health, USA
B Cell Biology in Acute and Chronic Infectious Diseases
B Cell Biology in Acute and Chronic Infectious Diseases
Short Talks Chosen from Abstracts
17:00—19:00
Control and Modulation of B Cell Responses
Frances E. Lund,
University of Alabama at Birmingham, USA
Cytokine-Producing “Effector” B Cells
Cytokine-Producing “Effector” B Cells
Darrell J. Irvine,
Massachusetts Institute of Technology, USA
Controlled Modulation of B Cell Responses
Controlled Modulation of B Cell Responses
Jenny Jiang,
University of Pennsylvania, USA
A Systems Approach to Understanding B Cell Fates
A Systems Approach to Understanding B Cell Fates
Short Talks Chosen from Abstracts
19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.
08:00—11:00
Rational Vaccine and Adjuvant (Joint)
William Schief,
The Scripps Research and IAVI, USA
Germline Targeting Strategies: mRNA EOD/Trimer Studies
Germline Targeting Strategies: mRNA EOD/Trimer Studies
Susan K. Pierce,
NIAID, National Institutes of Health, USA
Affinity Thresholds and Fate Decisions in Memory B Cells
Affinity Thresholds and Fate Decisions in Memory B Cells
Coffee Break
Andrew B. Ward,
The Scripps Research Institute, USA
HIV Structural Studies and implications for Vaccine Development
HIV Structural Studies and implications for Vaccine Development
Galit Alter,
Moderna, Inc., USA
Correlates of Antibody Immunity Against Infectious Diseases
Correlates of Antibody Immunity Against Infectious Diseases
Short Talks Chosen from Abstracts
17:00—19:00
Antigen Driven Activation, Selection and Metabolic Re-Programming
Pavel Tolar,
University College London, UK
Regulation of antigen persistence in germinal centres
Regulation of antigen persistence in germinal centres
Gabriel D. Victora,
Rockefeller University, USA
Evolution of Antibody Responses to Infection and Immunization
Evolution of Antibody Responses to Infection and Immunization
Jason G. Cyster,
HHMI/University of California, San Francisco, USA
Cell Migration Dynamics and Intercellular Communications Underlying Immunity
Cell Migration Dynamics and Intercellular Communications Underlying Immunity
Short Talks Chosen from Abstracts
17:00—19:00
Translational HIV Vaccine Research
Alejandro Balazs,
Massachusetts General Hospital, USA
Antibody-mediated Prevention of Vaginal HIV Transmission is Dictated by IgG Subclass in Humanized Mice
Antibody-mediated Prevention of Vaginal HIV Transmission is Dictated by IgG Subclass in Humanized Mice
Devin Sok,
International AIDS Vaccine Initiative, USA
IAVI Vaccine and Passive Antibody Trials in Africa
IAVI Vaccine and Passive Antibody Trials in Africa
Louis J. Picker,
Oregon Health & Science University, USA
Understanding the “Control and Clear” Efficacy of RhCMV/SIV Vaccine Vectors
Understanding the “Control and Clear” Efficacy of RhCMV/SIV Vaccine Vectors
Short Talks Chosen from Abstracts
19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.
08:00—11:00
Affinity Based Selection and Fate Decisions: Long Lived Plasma Cells and Memory B Cells
Frances Eun-Hyung Lee,
Emory University, USA
Talk Title to be Announced
Talk Title to be Announced
Coffee Break
Tomohiro Kurosaki,
Osaka University, Japan
Functional Fates of Memory B Cells
Functional Fates of Memory B Cells
Short Talks Chosen from Abstracts
08:00—11:00
Broadly Neutralizing Antibodies and Passive Immunization Against HIV and SARS-CoV-2
Penny L. Moore,
University of the Witwatersrand and National Institute for Communicable Diseases, South Africa
HIV B Cell Biology and Implications for Vaccine Development
HIV B Cell Biology and Implications for Vaccine Development
Marit van Gils,
Amsterdam UMC, Netherlands
Characterization and Application of Human bnabs to SARS-CoV-2
Characterization and Application of Human bnabs to SARS-CoV-2
Coffee Break
Laura M. Walker,
Adagio Therapeutics, USA
Virus-Specific Neutralizing Antibody Development
Virus-Specific Neutralizing Antibody Development
Short Talks Chosen from Abstracts
17:00—19:00
Activation and Redemption of the Autoreactive B Cell Repertoire in Autoimmune
Ignacio Sanz,
Emory University, School of Medicine, USA
B Cells and their Effector Progeny in Autoimmune Disease
B Cells and their Effector Progeny in Autoimmune Disease
Christopher C. Goodnow,
Garvan Institute of Medical Research, Australia
B Cell Self-Nonself Discrimination and Redemption
B Cell Self-Nonself Discrimination and Redemption
Jennifer L. Gommerman,
University of Toronto, Canada
B Cells in MS
B Cells in MS
Short Talks Chosen from Abstracts
17:00—19:00
Next Generation PrEP
Helen Rees,
University of the Witwatersrand, South Africa
Talk Title to be Announced
Talk Title to be Announced
Sharon Hillier,
University of Pittsburgh School of Medicine, USA
Dapivirine Ring
Dapivirine Ring
Moupali Das,
Gilead Sciences, USA
Lenacapavir Ultra-Long Acting
Lenacapavir Ultra-Long Acting
S. Rahima Benhabbour,
University of North Carolina, USA
Harnessing Innovative Engineering to Desing the Next Generation Long-Acting PrEP
Harnessing Innovative Engineering to Desing the Next Generation Long-Acting PrEP
Short Talks Chosen from Abstracts
19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.
08:00—11:00
The Impact of Infectious Disease and Inflammation on the B Cell Compartment
Carola G. Vinuesa,
Francis Crick Institute, UK
Mechanisms Underpinning Human Systemic Autoimmunity: Lessons from Inborn Errors of Immunity
Mechanisms Underpinning Human Systemic Autoimmunity: Lessons from Inborn Errors of Immunity
Marion Pepper,
University of Washington, USA
B Cell Response in Malaria
B Cell Response in Malaria
Coffee Break
Facundo D. Batista,
Massachusetts Institute of Technology and Harvard University, USA
Cell Metabolic Re-Programming
Cell Metabolic Re-Programming
Short Talks Chosen from Abstracts
08:00—11:00
Update on HIV Vaccine Trials
Hanneke Schuitemaker,
Janssen Vaccines & Prevention B.V., Netherlands
Ad26 Vaccines for COVID and HIV
Ad26 Vaccines for COVID and HIV
Margaret Juliana McElrath,
Fred Hutchinson Cancer Research Center, USA
HVTN Updates: Adjuvants and SOSIP Trimer Trials
HVTN Updates: Adjuvants and SOSIP Trimer Trials
Coffee Break
Hyman Scott,
University of California, San Francisco, USA
Talk Title to be Announced
Talk Title to be Announced
Glenda E. Gray,
South African Medical Research Council, South Africa
Next Generation of Efficacy Studies; Vaccine Development in era of Long Acting PrEP
Next Generation of Efficacy Studies; Vaccine Development in era of Long Acting PrEP
Short Talks Chosen from Abstracts
17:00—18:45
B Cell Malignancy Checkpoints and Targets of Therapies
Louis M. Staudt,
NCI, National Institutes of Health, USA
Curing Lymphoma by Understanding B Cell Biology
Curing Lymphoma by Understanding B Cell Biology
Sandrine Roulland,
Aix Marseille University, France
B Cell State Heterogeneity and Lymphomagenesis
B Cell State Heterogeneity and Lymphomagenesis
Karin Tarte,
INSERM U917 Université de Rennes 1, France
Follicular Lymphoma Microenvironment: Plasticity and Origin
Follicular Lymphoma Microenvironment: Plasticity and Origin
Short Talks Chosen from Abstracts
17:00—18:45
Leveraging HIV Prevention Advances for the Cure Agenda
Julie Ake,
Walter Reed Army Institute of Research, USA
Cure Approaches from NHP to Human
Cure Approaches from NHP to Human
Marina F. Caskey,
Rockefeller University, USA
bNabs-Eliciting Vaccine Strategies for HIV Cure
bNabs-Eliciting Vaccine Strategies for HIV Cure
Steven G. Deeks,
University of California, San Francisco, USA
Therapeutic Vaccination for HIV Cure
Therapeutic Vaccination for HIV Cure
Short Talks Chosen from Abstracts
19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.
*Session Chair †Invited, not yet responded.
We gratefully acknowledge additional support from these exhibitors at this conference:
|
|
Please stop by to meet these exhibitors during the conference.
We gratefully acknowledge additional support for this conference from:
|
|
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:
Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:
Click here to view more of these organizations
|
If your organization is interested in joining these entities in support of Keystone
Symposia, please contact: John Monson,
Director of Corporate Relations, Email: johnm@keystonesymposia.org, Phone:+1 970-262-2690 Click here for more information on Industry Support and Recognition Opportunities. If you are interested in becoming an advertising/marketing in-kind partner, please contact: Nick Dua, Senior Director, Communications, Email: nickd@keystonesymposia.org, Phone:+1 970-262-1179 |
